Home > Signaling Pathways>Cell Cycle>Aurora Kinase>Alisertib (MLN8237, MLN-8237)
Alisertib (MLN8237, MLN-8237)

This product is for research use only, not for human use. We do not sell to patients.

Alisertib (MLN8237, MLN-8237)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
100mg$340In Stock
250mg$620In Stock
500mg$930In Stock

Cat #: V0343 CAS #: 1028486-01-2 Purity ≥ 98%

Description: Alisertib (also named as MLN8237, MLN-8237) is a novel potent, selective, orally bioavailable Aurora A kinase (AAK) inhibitor with potential antitumor activity.

References: Güllü G, et al. A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma Blood June 24, 2010 vol. 115 no. 25 5202-5213.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)518.92
Molecular FormulaC27H20ClFN4O4
CAS No.1028486-01-2
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 27 mg/mL (52.0 mM)r
Water: <1 mg/mLr
Ethanol: <1 mg/mL
Solubility In Vivo15% Captisol: 5 mg/mL
SMILES CodeO=C(O)C1=CC=C(NC2=NC=C3C(C4=CC=C(Cl)C=C4C(C5=C(OC)C=CC=C5F)=NC3)=N2)C=C1OC
SynonymsMLN-8237; alisertib; MLN8237; MLN 8237
ProtocolIn VitroAlisertib (MLN 8237) leads the MM cells to mitotic spindle abnormalities, mitotic accumulation, as well as inhibition of cell proliferation through apoptosis and senescence. Alisertib up-regulates p53 and tumor suppressor genes p21 and p27.
In VivoAlisertib (MLN 8237) (30 mg/kg, p.o.) significantly reduces tumor burden and increases overall survival in xenograft-murine model of human-MM.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM1.9271 mL9.6354 mL19.2708 mL38.5416 mL
5mM0.3854 mL1.9271 mL3.8542 mL7.7083 mL
10mM0.1927 mL0.9635 mL1.9271 mL3.8542 mL
20mM0.0964 mL0.4818 mL0.9635 mL1.9271 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.